UTI Nifty Alpha Low-Volatility 30 Index Fund

A Equity Funds scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F1AZM9).

NAV ₹9.7251 on 16 November 2026.

Expense ratio

Total expense ratio 0.79% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.51%, brokerage 0.01%, transaction costs 0.00%, statutory levies including GST 0.27%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year-1.8%13.8%-13.4%-0.63-0.61

Too little NAV history for the 3, 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 99.7% of the portfolio.

  1. Torrent Pharmaceuticals Limited — 4.72%
  2. NTPC Limited — 4.10%
  3. Bajaj Auto Limited — 4.00%
  4. Marico Limited — 3.97%
  5. Apollo Hospitals Enterprise Limited — 3.91%
  6. Hindalco Industries Limited — 3.79%
  7. ICICI Bank Limited — 3.76%
  8. Nestle India Limited — 3.71%
  9. JSW Steel Limited — 3.61%
  10. Grasim Industries Limited — 3.60%

Plans

Other funds in Equity Funds

All 88 funds in Equity Funds · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.